MERS-CoV therapeutics (NanoViricides)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMERS-CoV therapeutics (NanoViricides)
Drug Alias NameMiddle East Respiratory Syndrome coronavirus infection (NanoViricides)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanoViricides Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanoViricides Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A